Abbvie Inc Stock Alpha and Beta Analysis

ABBV Stock  USD 224.81  0.46  0.21%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AbbVie Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in AbbVie over a specified time horizon. Remember, high AbbVie's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AbbVie's market risk premium analysis include:
Beta
(0.06)
Alpha
(0.03)
Risk
1.56
Sharpe Ratio
(0.01)
Expected Return
(0.01)
Please note that although AbbVie alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, AbbVie did 0.03  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of AbbVie Inc stock's relative risk over its benchmark. AbbVie Inc has a beta of 0.06  . As returns on the market increase, returns on owning AbbVie are expected to decrease at a much lower rate. During the bear market, AbbVie is likely to outperform the market. Book Value Per Share is likely to climb to -11.05 in 2026. Tangible Book Value Per Share is likely to drop to -12.22 in 2026.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out AbbVie Analysis, AbbVie Valuation, AbbVie Correlation, AbbVie Hype Analysis, AbbVie Volatility, AbbVie Price History and analyze AbbVie Performance.

AbbVie Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AbbVie market risk premium is the additional return an investor will receive from holding AbbVie long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AbbVie. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AbbVie's performance over market.
α-0.03   β-0.06

AbbVie expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AbbVie's Buy-and-hold return. Our buy-and-hold chart shows how AbbVie performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

AbbVie Market Price Analysis

Market price analysis indicators help investors to evaluate how AbbVie stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AbbVie shares will generate the highest return on investment. By understating and applying AbbVie stock market price indicators, traders can identify AbbVie position entry and exit signals to maximize returns.

AbbVie Return and Market Media

The median price of AbbVie for the period between Sun, Nov 23, 2025 and Sat, Feb 21, 2026 is 223.93 with a coefficient of variation of 2.13. The daily time series for the period is distributed with a sample standard deviation of 4.78, arithmetic mean of 224.09, and mean deviation of 3.92. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Top Medical Stocks To Add to Your Watchlist February 4th
02/04/2026
2
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year
02/10/2026
3
1 Reason Im Never Selling AbbVie Stock
02/12/2026
4
Where is AbbVie Inc. Headed According to the Street
02/13/2026
 
AbbVie dividend paid on 17th of February 2026
02/17/2026
6
Peering Into AbbVie Incs Recent Short Interest
02/18/2026
7
3 Stocks to Buy and Hold for 2026 and Beyond
02/19/2026

About AbbVie Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AbbVie or other stocks. Alpha measures the amount that position in AbbVie Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2025 2026 (projected)
Dividend Yield0.03850.02870.0283
Price To Sales Ratio5.046.693.57

AbbVie Upcoming Company Events

As portrayed in its financial statements, the presentation of AbbVie's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AbbVie's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AbbVie. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.
2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with AbbVie

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.